These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9394844)

  • 1. Tissue expression and serum levels of HER-2/neu in patients with breast cancer.
    Krainer M; Brodowicz T; Zeillinger R; Wiltschke C; Scholten C; Seifert M; Kubista E; Zielinski CC
    Oncology; 1997; 54(6):475-81. PubMed ID: 9394844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Her-2/neu extracellular domain in breast cancer patients-correlation with prognosis and clinicopathological parameters including steroid receptor, Her-2/neu receptor coexpression.
    Barić M; Kulić A; Sirotković-Skerlev M; Dedić Plavetić N; Vidović M; Horvatić-Herceg G; Vrbanec D
    Pathol Oncol Res; 2015 Jul; 21(3):589-95. PubMed ID: 25367073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum her-2/neu level and related factors in patients with breast cancer].
    Yuan P; Xu BH; Zhang C; Qi J
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):573-4. PubMed ID: 14690565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value.
    Molina R; Augé JM; Escudero JM; Filella X; Zanon G; Pahisa J; Farrus B; Muñoz M; Velasco M
    Tumour Biol; 2010 Jun; 31(3):171-80. PubMed ID: 20361287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
    Samy N; Ragab HM; El Maksoud NA; Shaalan M
    Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
    Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
    Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of HER2/neu oncoprotein in serum & tissue samples of women with breast cancer.
    Shukla S; Singh BK; Pathania OP; Jain M
    Indian J Med Res; 2016 May; 143(Supplement):S52-S58. PubMed ID: 27748278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia.
    Arafah M
    Turk Patoloji Derg; 2012; 28(1):38-43. PubMed ID: 22207430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-erbB-2 protein level in tissue and sera of breast cancer patients: a possibly useful clinical correlation.
    Quaranta M; Daniele A; Coviello M; Savonarola A; Abbate I; Venneri MT; Paradiso A; Stea B; Zito A; Labriola A; Schittulli F
    Tumori; 2006; 92(4):311-7. PubMed ID: 17036522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Her-2/neu and topoisomerase IIα in advanced breast cancer: a comprehensive FISH analysis of 245 cases.
    Engelstaedter V; Schiffers J; Kahlert S; Mainka P; Engel J; Kirchner T; Diebold J; Mayr D
    Diagn Mol Pathol; 2012 Jun; 21(2):77-83. PubMed ID: 22555090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
    Bhargava R; Naeem R; Marconi S; Luszcz J; Garb J; Gasparini R; Otis CN
    Hum Pathol; 2001 Dec; 32(12):1344-50. PubMed ID: 11774167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between serum HER-2 oncoprotein and patients with breast cancer.
    Yuan P; Xu BH; Chu DT
    Chin Med Sci J; 2004 Sep; 19(3):212-5. PubMed ID: 15506651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer.
    Wu Y; Khan H; Chillar R; Vadgama JV
    Int J Oncol; 1999 Jun; 14(6):1021-37. PubMed ID: 10339653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer.
    Ali SM; Leitzel K; Chinchilli VM; Engle L; Demers L; Harvey HA; Carney W; Allard JW; Lipton A
    Clin Chem; 2002 Aug; 48(8):1314-20. PubMed ID: 12142389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
    Shao Y; Sun X; He Y; Liu C; Liu H
    PLoS One; 2015; 10(7):e0133830. PubMed ID: 26207909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
    Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analyses of epidermal growth factor receptor and HER-2/neu: no advantage of prediction of recurrence or survival in breast cancer patients.
    Beckmann MW; Niederacher D; Massenkeil G; Tutschek B; Beckmann A; Schenko G; Schnürch HG; Bender HG
    Oncology; 1996; 53(6):441-7. PubMed ID: 8960138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of serum human epidermal receptor-2/neu detection in breast cancer patients.
    Thriveni K; Deshmane V; Bapsy PP; Krishnamoorthy L; Ramaswamy G
    Indian J Med Res; 2007 Feb; 125(2):137-42. PubMed ID: 17431282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
    Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.